Pfizer pfe stock forecast 2025 market outlook for Pfizer PFE stock

Market outlook for Pfizer PFE stock forecast 2025 shows potential dividend growth, supported by strong cash flow projections post-COVID revenue drop, appealing to defensive investors seeking stability in healthcare. Editor's Note: This analysis was originally published as a stock note by Morningstar Equity Research. That provided the short seller a one-month DTE yield of 1.13% (i.e., $0.26/$23.00). Today, those puts are trading for just 6 cents at the midpoint, so most of the yield has been made, even though there are still 17 days left to expiry. In other words, the trade has been successful. Analysts weighing Pfizer PFE stock forecast 2025 emphasize upcoming FDA approvals as potential catalysts; targeting a fair value around $40, assuming sustained margins amid inflationary cost pressures.